4//SEC Filing
RYLL TIMOTHY D 4
Accession 0001181431-06-038227
CIK 0001310094other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 2:37 PM ET
Size
5.5 KB
Accession
0001181431-06-038227
Insider Transaction Report
Form 4
RYLL TIMOTHY D
10% Owner
Transactions
- Other
Common Stock
2006-04-03$8.00/sh+5,339$42,712→ 3,634,160 total(indirect: By MOAB INVESTMENT, LP)
Footnotes (2)
- [F1]Represents the receipt of shares of common stock in lieu of accrued but unpaid dividends on the Company's former Series E Convertible Preferred Stock at a price of $8.00 a share.
- [F2]Mr. Ryll is the sole shareholder and sole director of MOAB Management Company, Inc., which is the sole general partner of MOAB Investments, LP. Mr. Ryll disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Documents
Issuer
ACCENTIA BIOPHARMACEUTICALS INC
CIK 0001310094
Entity typeother
Related Parties
1- filerCIK 0001331297
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 2:37 PM ET
- Size
- 5.5 KB